OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
797557

Lihit Lab Inc

Business Support SuppliesVerified

Lihit Lab Inc maintains a strong liquidity position, with a current ratio of 4.71, indicating the company can easily cover its short-term liabilities with its current assets. The company's cash and equivalents amount to ¥1,462,795,000, which provides a buffer against short-term obligations. The debt-to-equity ratio is 0.06, suggesting a conservative capital structure with minimal reliance on debt financing. In terms of profitability, Lihit Lab Inc reports a return on equity (ROE) of 0.58% and a return on assets (ROA) of 0.45%. These figures are below the typical thresholds for high-performing industrial services firms, indicating that the company is not generating substantial returns relative to its equity and asset base. The operating income of ¥74,564,000 and net income of ¥59,833,000 suggest modest profitability, with a gross profit of ¥800,460,000 contributing to the bottom line. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification may expose the company to higher operational and market risks if demand in its primary market fluctuates. Looking at the growth trajectory, Lihit Lab Inc's revenue for the latest period was ¥2,694,467,000, which is significantly higher than the analyst-estimated ¥9,124,180,000. This discrepancy suggests either a reporting period mismatch or a potential error in the analyst estimate. The company's growth outlook for the current fiscal year is not explicitly provided, but the modest net income and low ROE suggest limited growth potential in the near term. The risk assessment indicates low liquidity and dilution risks, with no immediate filing-based flags detected. The company's low debt-to-equity ratio and substantial cash reserves further support the low liquidity risk rating. However, the low ROE and ROA suggest that the company may need to explore new revenue streams or improve operational efficiency to enhance profitability. Recent events, including the latest financial filing and analyst estimates, indicate that the company is maintaining a stable financial position. The absence of significant changes in the capital structure or new strategic initiatives suggests a conservative approach to business operations.

30-day price · 7975+27.00 (+2.3%)
Low$1140.00High$1212.00Close$1200.00As of17 May, 00:00 UTC
Profile
CompanyLihit Lab Inc
Ticker7975.T
SectorIndustrials
BusinessIndustrial & Commercial Services
Industry groupIndustrial & Commercial Services
IndustryBusiness Support Supplies
AI analysis

Business. Lihit Lab Inc provides industrial services and business support supplies, primarily generating revenue through the sale of goods and services in the industrial and commercial services sector.

Classification. Lihit Lab Inc is classified under the industry "Business Support Supplies" within the "Industrial & Commercial Services" business sector, with a classification confidence of 0.92.

Lihit Lab Inc maintains a strong liquidity position, with a current ratio of 4.71, indicating the company can easily cover its short-term liabilities with its current assets. The company's cash and equivalents amount to ¥1,462,795,000, which provides a buffer against short-term obligations. The debt-to-equity ratio is 0.06, suggesting a conservative capital structure with minimal reliance on debt financing. In terms of profitability, Lihit Lab Inc reports a return on equity (ROE) of 0.58% and a return on assets (ROA) of 0.45%. These figures are below the typical thresholds for high-performing industrial services firms, indicating that the company is not generating substantial returns relative to its equity and asset base. The operating income of ¥74,564,000 and net income of ¥59,833,000 suggest modest profitability, with a gross profit of ¥800,460,000 contributing to the bottom line. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification may expose the company to higher operational and market risks if demand in its primary market fluctuates. Looking at the growth trajectory, Lihit Lab Inc's revenue for the latest period was ¥2,694,467,000, which is significantly higher than the analyst-estimated ¥9,124,180,000. This discrepancy suggests either a reporting period mismatch or a potential error in the analyst estimate. The company's growth outlook for the current fiscal year is not explicitly provided, but the modest net income and low ROE suggest limited growth potential in the near term. The risk assessment indicates low liquidity and dilution risks, with no immediate filing-based flags detected. The company's low debt-to-equity ratio and substantial cash reserves further support the low liquidity risk rating. However, the low ROE and ROA suggest that the company may need to explore new revenue streams or improve operational efficiency to enhance profitability. Recent events, including the latest financial filing and analyst estimates, indicate that the company is maintaining a stable financial position. The absence of significant changes in the capital structure or new strategic initiatives suggests a conservative approach to business operations.
Key takeaways
  • Lihit Lab Inc maintains a strong liquidity position with a current ratio of 4.71 and substantial cash reserves.
  • The company's profitability metrics, including ROE and ROA, are below industry benchmarks, indicating limited returns on equity and assets.
  • Revenue is concentrated in a single business segment, with no material geographic diversification reported.
  • The company's capital structure is conservative, with a low debt-to-equity ratio of 0.06.
  • No immediate liquidity or dilution risks were detected, but the company may need to improve profitability to sustain long-term growth.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$2.69B
Gross profit$800.5M
Operating income$74.6M
Net income$59.8M
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets$13.36B
Total liabilities$2.99B
Total equity$10.37B
Cash & equivalents$1.46B
Long-term debt$673.0M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$8.69B$343.3M$262.5M$379.5M
FY-3$8.51B-$155.2M-$24.4M$101.0M
FY-2$8.80B-$279.2M-$93.7M-$749.3M
FY-1$9.22B$178.0M$411.6M$316.6M
FY0$9.12B$31.2M$67.1M-$1.17B
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$13.33B$10.11B$2.26B
FY-3$12.73B$10.22B$1.08B
FY-2$13.12B$10.24B$1.24B
FY-1$13.43B$10.64B$2.33B
FY0$13.52B$10.98B$728.5M
PeriodOCFCapExFCFSBC
FY-4$720.7M-$112.1M$379.5M
FY-3-$745.7M-$79.9M$101.0M
FY-2$663.3M-$860.0M-$749.3M
FY-1$290.5M-$298.1M$316.6M
FY0$47.7M-$1.42B-$1.17B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$2.69B$74.6M$59.8M
FQ-6$2.08B-$11.0M-$16.6M
FQ-5$2.07B$302.0k$187.5M
FQ-4$2.37B$114.1M$180.9M
FQ-3$2.80B$14.3M$25.8M
FQ-2$2.08B-$12.3M$7.5M
FQ-1$1.91B-$39.4M-$5.2M
FQ0$2.33B$68.7M$38.9M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$13.36B$10.37B$1.46B
FQ-6$13.00B$10.27B$1.53B
FQ-5$13.39B$10.46B$2.81B
FQ-4$13.43B$10.64B$2.33B
FQ-3$13.07B$10.42B$659.5M
FQ-2$12.88B$10.54B$1.22B
FQ-1$13.22B$10.77B$1.21B
FQ0$13.52B$10.98B$728.5M
PeriodOCFCapExFCFSBC
FQ-7
FQ-6$606.3M-$86.8M
FQ-5
FQ-4$290.5M-$298.1M
FQ-3
FQ-2$544.8M-$1.29B
FQ-1
FQ0$47.7M-$1.42B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$10.37B
Net cash$789.8M
Current ratio4.7
Debt/Equity0.1
ROA0.4%
ROE0.6%
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Industrial Services · cohort 626 companies
Metric7975Activity
Op margin2.8%6.0% medp25 -2.1% · p75 13.4%below median
Net margin2.2%4.1% medp25 -2.2% · p75 10.8%below median
Gross margin29.7%28.8% medp25 19.4% · p75 44.6%above median
R&D / revenue2.7% medp25 2.4% · p75 3.1%
CapEx / revenue-5.0% medp25 -12.8% · p75 -1.9%
Debt / equity6.0%26.4% medp25 5.2% · p75 66.7%below median
Observations
IR observations
Last actual EPS19.77 JPY
Last actual revenue9,124,180,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-08 01:10 UTC#0faad0d3
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 03:39 UTCJob: bff738cc